Report Detail
Global Hemostats and Tissue Sealants Market Insights, Forecast to 2025
- RnM2717052 |
- 12 June, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Other
Blood clotting or coagulation, is an important process that eliminates excessive bleeding when a blood vessel is damaged. Platelets and proteins work together to stop the bleeding by forming a clot over the injury. Blood clottage is one of the mechanisms that reduce the loss of blood from damaged blood vessels. Hemostats and tissue sealants are used post-surgery or traumatic injury to bind or hold external tissue (skin) as well as internal tissue (blood vessels). Some key types of hemostats and tissue sealants include fibrin sealants, collagen-based compounds, synthetic agents, and tissue adhesive glues such as hydrogels and glutaraldehyde glues. Fibrin sealants have a wide range of medical applications.
The recent increase in number of out-patient surgeries is the prime driver for the growth of this market. Since these surgeries help to reduce the overall healthcare expenditure, they are increasingly being preferred by insurance payers to acquire reimbursements for their surgeries. Furthermore, as the out-patient surgeries do not require overnight stays, they are readily available to the patients.
The increasing use of fibrin sealants for hemostats aids is an emerging trend in this market. The use of fibrin sealants helps in the rapid formation of a stable clot and can also be applied to small blood vessels and to the areas that are difficult to reach with conventional sutures. Since there is minimal blood loss involved in this process, the use of fibrin sealants will witness a rapid increase during the forecast period.
The global Hemostats and Tissue Sealants market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hemostats and Tissue Sealants market based on company, product type, end user and key regions.
This report studies the global market size of Hemostats and Tissue Sealants in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hemostats and Tissue Sealants in these regions.
This research report categorizes the global Hemostats and Tissue Sealants market by top players/brands, region, type and end user. This report also studies the global Hemostats and Tissue Sealants market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Baxter
CR Bard
Johnson & Johnson
B.Braun
Cardinal Health
Cryolife
Neomend
Vivostat
Z-Medica
Market size by Product
Hemostats
Tissue Sealants
Market size by End User
Clinical Medicine
Scientific Research
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Hemostats and Tissue Sealants market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Hemostats and Tissue Sealants market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Hemostats and Tissue Sealants companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Hemostats and Tissue Sealants submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Hemostats and Tissue Sealants are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hemostats and Tissue Sealants market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Hemostats and Tissue Sealants Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Hemostats and Tissue Sealants Market Size Growth Rate by Product
- 1.4.2 Hemostats
- 1.4.3 Tissue Sealants
- 1.5 Market by End User
- 1.5.1 Global Hemostats and Tissue Sealants Market Size Growth Rate by End User
- 1.5.2 Clinical Medicine
- 1.5.3 Scientific Research
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Hemostats and Tissue Sealants Market Size
- 2.1.1 Global Hemostats and Tissue Sealants Revenue 2014-2025
- 2.1.2 Global Hemostats and Tissue Sealants Sales 2014-2025
- 2.2 Hemostats and Tissue Sealants Growth Rate by Regions
- 2.2.1 Global Hemostats and Tissue Sealants Sales by Regions
- 2.2.2 Global Hemostats and Tissue Sealants Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Hemostats and Tissue Sealants Sales by Manufacturers
- 3.1.1 Hemostats and Tissue Sealants Sales by Manufacturers
- 3.1.2 Hemostats and Tissue Sealants Sales Market Share by Manufacturers
- 3.1.3 Global Hemostats and Tissue Sealants Market Concentration Ratio (CR5 and HHI)
- 3.2 Hemostats and Tissue Sealants Revenue by Manufacturers
- 3.2.1 Hemostats and Tissue Sealants Revenue by Manufacturers (2014-2019)
- 3.2.2 Hemostats and Tissue Sealants Revenue Share by Manufacturers (2014-2019)
- 3.3 Hemostats and Tissue Sealants Price by Manufacturers
- 3.4 Hemostats and Tissue Sealants Manufacturing Base Distribution, Product Types
- 3.4.1 Hemostats and Tissue Sealants Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Hemostats and Tissue Sealants Product Type
- 3.4.3 Date of International Manufacturers Enter into Hemostats and Tissue Sealants Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Hemostats and Tissue Sealants Sales by Product
- 4.2 Global Hemostats and Tissue Sealants Revenue by Product
- 4.3 Hemostats and Tissue Sealants Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Hemostats and Tissue Sealants Breakdown Data by End User
6 North America
- 6.1 North America Hemostats and Tissue Sealants by Countries
- 6.1.1 North America Hemostats and Tissue Sealants Sales by Countries
- 6.1.2 North America Hemostats and Tissue Sealants Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Hemostats and Tissue Sealants by Product
- 6.3 North America Hemostats and Tissue Sealants by End User
7 Europe
- 7.1 Europe Hemostats and Tissue Sealants by Countries
- 7.1.1 Europe Hemostats and Tissue Sealants Sales by Countries
- 7.1.2 Europe Hemostats and Tissue Sealants Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Hemostats and Tissue Sealants by Product
- 7.3 Europe Hemostats and Tissue Sealants by End User
8 Asia Pacific
- 8.1 Asia Pacific Hemostats and Tissue Sealants by Countries
- 8.1.1 Asia Pacific Hemostats and Tissue Sealants Sales by Countries
- 8.1.2 Asia Pacific Hemostats and Tissue Sealants Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Hemostats and Tissue Sealants by Product
- 8.3 Asia Pacific Hemostats and Tissue Sealants by End User
9 Central & South America
- 9.1 Central & South America Hemostats and Tissue Sealants by Countries
- 9.1.1 Central & South America Hemostats and Tissue Sealants Sales by Countries
- 9.1.2 Central & South America Hemostats and Tissue Sealants Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Hemostats and Tissue Sealants by Product
- 9.3 Central & South America Hemostats and Tissue Sealants by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Hemostats and Tissue Sealants by Countries
- 10.1.1 Middle East and Africa Hemostats and Tissue Sealants Sales by Countries
- 10.1.2 Middle East and Africa Hemostats and Tissue Sealants Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Hemostats and Tissue Sealants by Product
- 10.3 Middle East and Africa Hemostats and Tissue Sealants by End User
11 Company Profiles
- 11.1 Baxter
- 11.1.1 Baxter Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Baxter Hemostats and Tissue Sealants Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Baxter Hemostats and Tissue Sealants Products Offered
- 11.1.5 Baxter Recent Development
- 11.2 CR Bard
- 11.2.1 CR Bard Company Details
- 11.2.2 Company Business Overview
- 11.2.3 CR Bard Hemostats and Tissue Sealants Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 CR Bard Hemostats and Tissue Sealants Products Offered
- 11.2.5 CR Bard Recent Development
- 11.3 Johnson & Johnson
- 11.3.1 Johnson & Johnson Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Johnson & Johnson Hemostats and Tissue Sealants Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Johnson & Johnson Hemostats and Tissue Sealants Products Offered
- 11.3.5 Johnson & Johnson Recent Development
- 11.4 B.Braun
- 11.4.1 B.Braun Company Details
- 11.4.2 Company Business Overview
- 11.4.3 B.Braun Hemostats and Tissue Sealants Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 B.Braun Hemostats and Tissue Sealants Products Offered
- 11.4.5 B.Braun Recent Development
- 11.5 Cardinal Health
- 11.5.1 Cardinal Health Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Cardinal Health Hemostats and Tissue Sealants Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Cardinal Health Hemostats and Tissue Sealants Products Offered
- 11.5.5 Cardinal Health Recent Development
- 11.6 Cryolife
- 11.6.1 Cryolife Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Cryolife Hemostats and Tissue Sealants Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Cryolife Hemostats and Tissue Sealants Products Offered
- 11.6.5 Cryolife Recent Development
- 11.7 Neomend
- 11.7.1 Neomend Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Neomend Hemostats and Tissue Sealants Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Neomend Hemostats and Tissue Sealants Products Offered
- 11.7.5 Neomend Recent Development
- 11.8 Vivostat
- 11.8.1 Vivostat Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Vivostat Hemostats and Tissue Sealants Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Vivostat Hemostats and Tissue Sealants Products Offered
- 11.8.5 Vivostat Recent Development
- 11.9 Z-Medica
- 11.9.1 Z-Medica Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Z-Medica Hemostats and Tissue Sealants Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Z-Medica Hemostats and Tissue Sealants Products Offered
- 11.9.5 Z-Medica Recent Development
12 Future Forecast
- 12.1 Hemostats and Tissue Sealants Market Forecast by Regions
- 12.1.1 Global Hemostats and Tissue Sealants Sales Forecast by Regions 2019-2025
- 12.1.2 Global Hemostats and Tissue Sealants Revenue Forecast by Regions 2019-2025
- 12.2 Hemostats and Tissue Sealants Market Forecast by Product
- 12.2.1 Global Hemostats and Tissue Sealants Sales Forecast by Product 2019-2025
- 12.2.2 Global Hemostats and Tissue Sealants Revenue Forecast by Product 2019-2025
- 12.3 Hemostats and Tissue Sealants Market Forecast by End User
- 12.4 North America Hemostats and Tissue Sealants Forecast
- 12.5 Europe Hemostats and Tissue Sealants Forecast
- 12.6 Asia Pacific Hemostats and Tissue Sealants Forecast
- 12.7 Central & South America Hemostats and Tissue Sealants Forecast
- 12.8 Middle East and Africa Hemostats and Tissue Sealants Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Hemostats and Tissue Sealants Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Hemostats and Tissue Sealants . Industry analysis & Market Report on Hemostats and Tissue Sealants is a syndicated market report, published as Global Hemostats and Tissue Sealants Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Hemostats and Tissue Sealants market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
